Attention #bladdercancer researchers! BCAN is hosting a webinar about available funding opportunities for medical research through the Congressionally Directed Medical Research Programs (CDMRP) for 2024. April 17th at 12:00 pm ET. Register here: us02web.zoom.us/webinar/regist…

Calling all #bladdercancer #researchers : Last chance to submit your LOI for Bladder Cancer Advocacy Network Innovation Awards due 1/12. $300k over 2 years: tinyurl.com/Innovation24.
Watch this space for the launch of our 2024 YIAs later this week! tinyurl.com/BCAN24

In European Pharmaceutical Review: New 36-month follow-up data from a Ferring Pharmaceuticals U.S. Phase III study demonstrated a sustained durability of response for patients given the gene therapy Adstiladrin. Click here to read more: europeanpharmaceuticalreview.com/news/189443/fe…

Announcing Bladder Cancer Advocacy Network
#Research #Innovation Award is now open! Accepting LOIs until 1/12/24. Two awards for $300k for high-risk/high-reward science. Apply now and share! tinyurl.com/Innovation24 Molly Ingersoll Joshua Meeks Max Kates Petros Grivas Sarah P. Psutka MD MS Peter Clark MD

The Society for Immunotherapy of Cancer and IBCG
Expert Panel generated recommendations for effective UC clinical trial designs with the goal of providing standardized criteria to generate comparable and robust data and accelerate the development of new therapies. doi.org/10.1200/jco.23…

Don't miss your chance to apply! Only 1 week until Bladder Cancer Advocacy Network CDA applications are due! 3 year $250,000 grant to support translational clinical or epi #bladdercancer research. tinyurl.com/BCANCDA

Our study is finally online European Urology! doi.org/10.1016/j.euru……

▶️Pre-op plasma ctDNA predicts muscle invasive #UTUC on surgical specimen
▶️ctDNA prognostic of post-surgical outcomes

Amazing collaboration with Dr. Bishoy M. Faltas Andrea Necchi Joshua Meeks Predicine, Inc. Moffitt Urologic Oncology Fellowship

Are you an investigator within the initial 7 years of your first full-time faculty appointment? Do you have innovative ideas for #bladdercancer research? If so, apply for BCAN's Career Development Award, $250,000 for 3 years. Click to learn more: bcan.org/bcan-research/…

Bladder cancer is the 6th most common cancer in the U.S. With a new grant from Bladder Cancer Advocacy Network, KU researcher John Taylor, M.D., will study the reasons that people with Down syndrome are less likely to develop cancer in order to find new treatments: bit.ly/3R9yWjg

Don't miss a multidisciplinary symposium on State of the Art Mgmt. of HR #NMIBC at the 23' Annual Meeting of the New England Section of the Amer. Urol. Assn.! Saturday Sept 9th - bit.ly/3QZjLZJ University of Massachusetts Guru P. Sonpavde, MD Matthew Mossanen @KMittalMD Kent Mouw Pfizer Inc. Bladder Cancer Advocacy Network

NOW OPEN! BCAN's Career Development Award is accepting applications, but only until October 18th! $250,000 for one year of innovative research to improve #bladdercancer patient outcomes. Click here to learn more and apply: bcan.org/bcan-research/…

Mentors pls share! Less than 1 week until Bladder Cancer Advocacy Network CDA opens for applications on 8/30! Start preparing your app now. 3 year $250,000 grant to support translational clinical or epi #bladdercancer research. Guidelines posted here soon: tinyurl.com/BCANCDA

📢📢Providers who treat pts w/ advanced #bladdercancer . Consider answering this 5 min SURVEY on Tx decisions for platinum-ineligible BCa as we face platinum shortages: redcap.ihrp.uic.edu/surveys/?s=NJK…
$10 donation to Bladder Cancer Advocacy Network in thanks!

Dr. Laura Bukavina (Laura Bukavina) highlights ongoing work in understanding the role of the microbiome in bladder cancer care. #urology #urologist #bladdercancer #BCANTT23 University Hospitals Urology Institute Bladder Cancer Advocacy Network

Read the full discussion here: urologytimes.com/view/the-poten…

in CURE Today: Prehabilitation can be beneficial for patients who are about to undergo cancer treatment such as surgery or radiation, but can also help to make an individual eligible for a certain therapies, too, explained Sarah P. Psutka MD MS. Click to watch: curetoday.com/view/prehab-he…

Gemcitabine and docetaxel therapy associated with better outcomes than BCG therapy for high-risk #NMIBC . Vignesh Packiam, MD University of Iowa Urology joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss this retrospective cohort study on UroToday > bit.ly/44dO6He

Deeply humbled to be featured in Oncology Times, reflecting on my journey from Ethiopia to Boston and my work in bladder cancer. 🧬 #BladderCancerResearch #OncologyTimes journals.lww.com/oncology-times…

Join Angie Smith Urology@UNC and Zach Klaassen Georgia Cancer Center in this UroToday discussion as they discuss the benefits of coaching in the field of urology, overcoming burnout, and the importance of mentorship. #WatchNow the > bit.ly/42gw1r5 #AUA23

.Scott Tagawa continues his discussion with Urology Times weighing in on the current status of the #BladderCancer #chemotherapy drug shortage: bit.ly/3OuBBRt

Two weeks left until BCAN's Career Development Award (CDA) opens for applications on 8/30. A 3 year $250,000 grant that will support translational clinical or epidemiological #bladdercancer research. Visit: bcan.org/bcan-research/….